Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 51 results:
Author Title [ Type(Desc)] Year
Filters: Author is Quint, J. K.  [Clear All Filters]
Journal Article
H. R. Whittaker, Bloom, C., Morgan, A., Jarvis, D., Kiddle, S. J., and Quint, J. K., “Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients”, Eur Respir J, 2020.
M. F. Barakat, McDonald, H. I., Collier, T. J., Smeeth, L., Nitsch, D., and Quint, J. K., “Acute kidney injury in stable COPD and at exacerbation”, Int J Chron Obstruct Pulmon Dis, vol. 10, pp. 2067-77, 2015.
C. I. Bloom, Cabrera, C., Arnetorp, S., Coulton, K., Nan, C., van der Valk, R. J. P., and Quint, J. K., “Asthma-Related Health Outcomes Associated with Short-Acting β(2)-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program”, Adv Ther, 2020.
V. Navaratnam, Millett, E. R., Hurst, J. R., Thomas, S. L., Smeeth, L., Hubbard, R. B., Brown, J., and Quint, J. K., “Bronchiectasis and the risk of cardiovascular disease: a population-based study”, Thorax, vol. 72, pp. 161-166, 2017.
K. Ngaosuwan, Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N., and Robinson, S., “Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities”, J Clin Endocrinol Metab, 2021.
J. K. Quint, Millett, E. R., Joshi, M., Navaratnam, V., Thomas, S. L., Hurst, J. R., Smeeth, L., and Brown, J. S., “Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study”, Eur Respir J, vol. 47, pp. 186-93, 2016.
A. V. Gayle, Axson, E. L., Bloom, C. I., Navaratnam, V., and Quint, J. K., “Changing causes of death for patients with chronic respiratory disease in England, 2005-2015”, Thorax, 2019.
H. R. Whittaker, Pimenta, J. M., Jarvis, D., Kiddle, S. J., and Quint, J. K., “Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 3079-3091, 2020.
A. D. Morgan, Rothnie, K. J., Bhaskaran, K., Smeeth, L., and Quint, J. K., “Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data”, Thorax, vol. 73, pp. 877-879, 2018.
F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
K. J. Rothnie, Smeeth, L., Herrett, E., Pearce, N., Hemingway, H., Wedzicha, J., Timmis, A., and Quint, J. K., “Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease”, Heart, vol. 101, pp. 1103-10, 2015.
K. Mansfield, Crellin, E., Denholm, R., Quint, J. K., Smeeth, L., Cook, S., and Herrett, E., “Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study”, BMJ Open, vol. 9, p. e031537, 2019.
F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care”, Br J Gen Pract, vol. 68, pp. e775-e782, 2018.
A. D. Morgan, Herrett, E., De Stavola, B. L., Smeeth, L., and Quint, J. K., “COPD disease severity and the risk of venous thromboembolic events: a matched case-control study”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 899-908, 2016.
C. I. Bloom, Douglas, I., Olney, J., D'Ancona, G., Smeeth, L., and Quint, J. K., “Cost saving of switching to equivalent inhalers and its effect on health outcomes”, Thorax, 2019.
J. K. Quint, O'Leary, C., Venerus, A., Holmgren, U., Varghese, P., and Cabrera, C., “Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study”, Pulm Ther, 2020.
J. K. Quint, Herrett, E., Bhaskaran, K., Timmis, A., Hemingway, H., Wedzicha, J. A., and Smeeth, L., “Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records”, Bmj, vol. 347, p. f6650, 2013.
E. Moore, Newson, R., Joshi, M., Palmer, T., Rothnie, K. J., Singh, S., Majeed, A., Soljak, M., and Quint, J. K., “Effects of Pulmonary Rehabilitation on Exacerbation Number and Severity in People With COPD: An Historical Cohort Study Using Electronic Health Records”, Chest, vol. 152, pp. 1188-1202, 2017.
H. Whittaker, Connell, O., Campbell, J., Elbehairy, A. F., Hopkinson, N. S., and Quint, J. K., “Eligibility for Lung Volume Reduction Surgery in Chronic Obstructive Pulmonary Disease patients identified in a UK primary care setting”, Chest, 2019.
C. I. Bloom, Nissen, F., Douglas, I. J., Smeeth, L., Cullinan, P., and Quint, J. K., “Exacerbation risk and characterisation of the UK's asthma population from infants to old age”, Thorax, vol. 73, pp. 313-320, 2018.
D. R. Morales, Flynn, R., Zhang, J., Trucco, E., Quint, J. K., and Zutis, K., “External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches”, Respir Med, vol. 138, pp. 150-155, 2018.
G. Requena, Wolf, A., Williams, R., Dedman, D., Quint, J. K., Murray-Thomas, T., and Pimenta, J. M., “Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials”, Pharmacoepidemiol Drug Saf, 2020.
M. Pikoula, Quint, J. K., Nissen, F., Hemingway, H., Smeeth, L., and Denaxas, S., “Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records”, BMC Med Inform Decis Mak, vol. 19, p. 86, 2019.
E. R. Millett, Quint, J. K., De Stavola, B. L., Smeeth, L., and Thomas, S. L., “Improved incidence estimates from linked vs. stand-alone electronic health records”, J Clin Epidemiol, vol. 75, pp. 66-9, 2016.
C. I. Bloom, Walker, S., and Quint, J. K., “Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017”, J Asthma, pp. 1-7, 2019.
E. R. Millett, Quint, J. K., Smeeth, L., Daniel, R. M., and Thomas, S. L., “Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study”, PLoS One, vol. 8, p. e75131, 2013.
A. Gayle, Dickinson, S., Poole, C., Pang, M., Fauconnot, O., and Quint, J. K., “Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study”, NPJ Prim Care Respir Med, vol. 29, p. 28, 2019.
K. Ngaosuwan, Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N., and Robinson, S., “Increased mortality risk in patients with primary and secondary adrenal insufficiency”, J Clin Endocrinol Metab, 2021.
K. E. Mansfield, Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., Matthews, A. A., Bidulka, P., Gayle, A., Forbes, H., Cook, S., Wong, A. Y. S., Strongman, H., Wing, K., Warren-Gash, C., Cadogan, S. L., Smeeth, L., Hayes, J. F., Quint, J. K., McKee, M., and Langan, S. M., “Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study”, Lancet Digit Health, 2021.
H. R. Whittaker, Mullerova, H., Jarvis, D., Barnes, N. C., Jones, P. W., Compton, C. H., Kiddle, S. J., and Quint, J. K., “Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting”, Int J Chron Obstruct Pulmon Dis, vol. 14, pp. 1063-1073, 2019.
K. J. Rothnie, Connell, O., Mullerova, H., Smeeth, L., Pearce, N., Douglas, I., and Quint, J. K., “Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease”, Ann Am Thorac Soc, vol. 15, pp. 935-946, 2018.
K. J. Rothnie, Mullerova, H., Smeeth, L., and Quint, J. K., “Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease”, Am J Respir Crit Care Med, vol. 198, pp. 464-471, 2018.
C. Windsor, Herrett, E., Smeeth, L., and Quint, J. K., “No association between exacerbation frequency and stroke in patients with COPD”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 217-25, 2016.
E. L. Axson, Bloom, C. I., and Quint, J. K., “Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016”, Eur J Clin Microbiol Infect Dis, vol. 37, pp. 1795-1803, 2018.
C. I. Bloom, Ricciardi, F., Smeeth, L., Stone, P., and Quint, J. K., “Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care”, BMC Med, vol. 17, p. 73, 2019.
S. J. Kiddle, Whittaker, H. R., Seaman, S. R., and Quint, J. K., “Prediction of five-year mortality after COPD diagnosis using primary care records”, PLoS One, vol. 15, p. e0236011, 2020.
J. K. Quint, O'Leary, C., Venerus, A., Myland, M., Holmgren, U., Varghese, P., Richter, H., Bizouard, G., and Cabrera, C., “Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease”, Pulm Ther, vol. 6, pp. 333-350, 2020.
J. K. Quint, Venerus, A., O'Leary, C., Myland, M., Holmgren, U., Varghese, P., and Cabrera, C., “Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 3261-3271, 2020.
K. Wing, Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., Quint, J. K., and Douglas, I., “Real world effects of COPD medications: a cohort study with validation against RCT results”, Eur Respir J, 2020.
K. Wing, Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., Quint, J. K., and Douglas, I., “Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results”, BMJ Open, vol. 8, p. e019475, 2018.
K. J. Rothnie, Mullerova, H., Thomas, S. L., Chandan, J. S., Smeeth, L., Hurst, J. R., Davis, K., and Quint, J. K., “Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records”, Clin Epidemiol, vol. 8, pp. 771-782, 2016.
J. K. Quint, Moore, E., Lewis, A., Hashmi, M., Sultana, K., Wright, M., Smeeth, L., Chatzidiakou, L., Jones, R., Beevers, S., Kolozali, S., Kelly, F., and Barratt, B., “Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research”, NPJ Prim Care Respir Med, vol. 28, p. 21, 2018.
E. L. Axson, Bual, N., Bloom, C. I., and Quint, J. K., “Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK”, Eur J Clin Microbiol Infect Dis, 2018.
E. R. Millett, De Stavola, B. L., Quint, J. K., Smeeth, L., and Thomas, S. L., “Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study”, BMJ Open, vol. 5, p. e008737, 2015.
E. L. Axson, Sundaram, V., Bloom, C. I., Bottle, A., Cowie, M. R., and Quint, J. K., “Temporal Trends in the Incidence of Heart Failure among Patients with COPD and Its Association with Mortality”, Ann Am Thorac Soc, 2020.
J. L. Walker, Grint, D. J., Strongman, H., Eggo, R. M., Peppa, M., Minassian, C., Mansfield, K. E., Rentsch, C. T., Douglas, I. J., Mathur, R., Wong, A. Y. S., Quint, J. K., Andrews, N., Bernal, J. L., Scott, J. A., Ramsay, M., Smeeth, L., and McDonald, H. I., “UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records”, BMC Public Health, vol. 21, p. 484, 2021.
G. Requena, Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., and Pimenta, J. M., “The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study”, Int J Chron Obstruct Pulmon Dis, vol. 16, pp. 629-642, 2021.
F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 7, p. e017474, 2017.
J. K. Quint, Mullerova, H., DiSantostefano, R. L., Forbes, H., Eaton, S., Hurst, J. R., Davis, K., and Smeeth, L., “Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)”, BMJ Open, vol. 4, p. e005540, 2014.
K. J. Rothnie, Mullerova, H., Hurst, J. R., Smeeth, L., Davis, K., Thomas, S. L., and Quint, J. K., “Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records”, PLoS One, vol. 11, p. e0151357, 2016.
[Page last reviewed 4 May 2021]